Article ID Journal Published Year Pages File Type
8230153 International Journal of Radiation Oncology*Biology*Physics 2011 7 Pages PDF
Abstract
The combination of full-dose gemcitabine, bevacizumab, and radiotherapy was active and was not associated with a high rate of major surgical complications.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase II Trial of Full-Dose Gemcitabine and Bevacizumab in Combination With Attenuated Three-Dimensional Conformal Radiotherapy in Patients With Localized Pancreatic Cancer
Authors
, , , , , , ,